About Us
Stroke
Our Product
Partners & Investors
News & Media
Contact
ACTIMIS Study

About Us

Nothing to display, yet.

About Us

Company Overview
Board of Directors
Project Team
Scientific founders

December 22, 2020

Acticor Biotech Announces the Recruitment of the First Patient in its Phase 2 GARDEN Study in COVID-19_related ARDS

– Approval of phase 2 GARDEN study in France and Brazil – GARDEN will enroll 60 patients hospitalized for COVID19 – First Patient included at University Hospital of Strasbourg Paris, December 22th, 2020 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announces […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors
ACTIMIS Study

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn
Careers

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18